Peng Kuan Chan
Independent Non-Executive DirectorMr. Peng Kuan Chan, also known as Tony, was Deputy CEO & CFO of Elegance Optical International Holdings Limited from August 08, 2018. serves as Independent Non-Executive Director at VISEN Pharmaceuticals (Shanghai) Co., Ltd. since April 01, 2021. He is Independent Non-Executive Director of JW (Cayman) Therapeutics Co. Ltd from August 28, 2024. Mr. Chan has been independent non-executive Director of Yonghe Medical Group Co., Ltd. since June 1, 2021. He has been an Independent Non-executive Director at VISEN Pharmaceuticals since April 1, 2021. He serves as an Independent Non-Executive Director at CANbridge Life Sciences Ltd. since June 11, 2021. Mr. Chan serves as Independent non-executive Director at Canbridge Limited since June 11, 2021. Mr. Chan has been Independent Non-Executive Director of CANbridge Pharmaceuticals Inc. since June 11, 2021. He is responsible for providing independent advice and judgment at Yonghe Medical Group Co., Ltd. He serves as the Chief Operating Officer of CITIC Merchant Co., Limited. Mr. Chan has more years of experience incorporate finance and investment banking. Mr. Chan was the Managing Director at Sanyuan Group Limited. Mr. Chan has extensive experience in investment banking, auditing, securities research and direct investments. Prior to joining China Bio-medical Group Ltd. in August 2000, Mr. Chan was an executive director of an international investment bank, at which he gained extensive experience in initial public offerings, merger and acquisitions, corporate restructuring and financial advisory. He served as a Non Executive Director of CIAM Group Limited from April 20, 2012 to May 31, 2013. Mr. Chang served as an Independent Non-Executive Director at Yincheng International Holding Co Ltd., since February 18, 2019 until November 16, 2024. He served as an Executive Director of Sanyuan Group Limited from August 15, 2000 to December 4, 2004. Mr. Chan served as a Director of Pacific Engineering Limited (‘‘PEL’’) from August 31, 2000 to January 29, 2003 and served as Director of Infinity Properties Limited, Propland Limited and V&O Company Limited (collectively, the ‘‘Relevant Companies’’), all of which were incorporated in Hong Kong and wholly-owned subsidiaries of Sanyuan. Mr. Chan is a chartered accountant in New Zealand, a member of the Hong Kong Society of Accountants, a senior associate of the Australasian Institute of Banking and Finance and a member of the Hong Kong Securities Institute. He is a Chartered Accountant of the Institute of Chartered Accountants of Australia and New Zealand and a Certified Public Accountant of the Hong Kong Institute of Certified Public Accountants. Mr. Chan graduated from University of Canterbury in New Zealand in 1989 with a Bachelor of Commerce degree and obtained a Master of Applied Finance degree from Macquarie University in Australia in 1998.
Positions
- Company NameVISEN PharmaceuticalsStock Code02561PositionIndependent Non-Executive DirectorColleagues
- Company NameYonghe Medical Group Co., Ltd.Stock Code02279PositionIndependent Non-Executive DirectorColleagues
- YZYu ZhangChairman of the Board & CEO
- ZHZhimei HanExecutive Director, Finance Director, CFO & Joint Company Secretary
- HZHui ZhangSenior VP of the Integrated Management Center & Executive Director
- YXYang XuChief Executive Officer of Innovation Business Unit
- JRJian RenChief Growth Officer
- JGJiaqi GengNon-Executive Director
- Company NameCANbridge Pharmaceuticals Inc.Stock Code01228PositionIndependent Non-Executive DirectorColleagues
- QXQun XueFounder, Chairman of the Board, CEO & Member of Strategic Advisory Board
- LZLillian ZhangSenior Director & Head of Finance Operations and Controller
- JSJoe ShenChief Operating Officer
- QMQian MaVice President, Company Secretary & General Counsel
- CCChris ChenSenior Vice President of Human Resources
- RJRichard James GregoryIndependent Non-Executive Director
- PKPeng Kuan ChanIndependent Non-Executive Director
- JAJames Arthur GeraghtyIndependent Non-Executive Director
- MAMark Alan GoldbergMember of Strategic Advisory Board
